期刊文献+

乙肝疫苗新型佐剂CpG-BW006对小鼠脾NK细胞表面分子CD69的表达及γ干扰素分泌的影响 被引量:1

Influences of CpG Adjuvant BW006 of Hepatitis B Vaccine on Mu rine Spleen NK Cells Surface CD69 Expression and IFN-γ Secretion
下载PDF
导出
摘要 目的:研究重组乙型肝炎表面抗原(HBsAg)佐剂BW006对小鼠脾自然杀伤(NK)细胞表面分子CD69的表达和γ干扰素(IFN-γ)分泌水平的影响。方法:BW006、HBsAg单用或联用体外刺激小鼠脾NK细胞,流式细胞仪检测NK细胞膜表面分子CD69的表达水平,ELISA检测IFN-γ的分泌水平。结果:5μg BW006体外刺激小鼠脾NK细胞24 h后,NK细胞表面分子CD69的表达达峰值(阳性率45.18%),显著高于40μg HBsAg组(21.44%)(P<0.05),与5μg BW006和40μg HBsAg联用组(58.49%)相比无显著差异;24 h时,5μg BW006组的IFN-γ分泌水平达56.95ng/mL,显著高于40μg HBsAg组(8.74 ng/mL)(P<0.05),与联用组(57.70 ng/mL)相比无显著差异。结论:BW006具有上调NK细胞表面分子CD69表达和诱导IFN-γ分泌的早期活化NK细胞的功能,作为疫苗的新型佐剂前景较好。 Objective: To study the influences of CpG adjuvant BW006 for hepatitis B vaccine on the pheno- type and functions of murine spleen natural killer(NK) cells. Methods: After murine spleen NK cells were stimu- lated with BW006 and/or HBsAg in vitro, the expression of CD69 on NK cells surface was analyzed by flow cy- tometer and the secretion level of IFN-~/ was detected by ELISA. Results: After 24 hours of stimulation, the ex- pression of CD69 reached peak and the expression rate was 48.18% which was significantly higher than 40 p,g HBsAg group(21.44%, P〈0.05). However, the expression of CD69 on NK cells surface have no significant differ- ence in 5 p,g BW006 group and 5 ug BW006 combined with 40 p,g HBsAg group(58.49%). The IFN-'y secre- tion levels of murine spleen NK cells was up to 56.95 ng/mL after activating with 5 p^g BW006 which was signifi- cantly higher than 40 Ixg HBsAg group (8.47 ng/mL, P〈0.05). However, the IFN-y secretion levels of routine spleen NK cells have no significant difference in 5 p,g BW006 group and 5 μg BWO06 combined with 40 &g HB- sag group(57.70%). Conclusion: BW006 functions to activate NK cells on early stage, regulate expression of CD69 and induce IFN-y secretion, indicating BW006 to be a novel promising vaccine adjuvant.
出处 《生物技术通讯》 CAS 2013年第2期219-221,共3页 Letters in Biotechnology
关键词 自然杀伤细胞 CPG-ODN 重组乙型肝炎表面抗原 IFN-γ natural killer cells CpG-ODN rHBsAg IFN-y
  • 相关文献

参考文献12

  • 1Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection[J]. Nat Rev hnmunnol, 2005,5:215-229.
  • 2Worht Health Organization. Programmes and projects - Immunization service delivery and accelerated disease control - New vaccines and technologies- Hepatitis B[EB/OL]. 2008. http://www.who.int/immunization_delivery/new_vaeeines/hepb/en/ index.html.
  • 3Liang X F, Bi S L, Yang W Z, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine. 2009,27:6550-6557.
  • 4Hem S L, Hogenesch H. Relationship between physical and chemical properties of aluminum-containing adjuvants and im- munopotentiation[J]. Exp Rev Vaccines, 2007,6:685-698.
  • 5Lee W M. Hepatitis B virus infection[J]. N Engl J Med, 1997, 337:1733-1745.
  • 6Memarnejadian A, Roohvand F. Fusion of HBsAg and prime/ boosting augment Thl and CTL responses to HCV polytope DNA vaccine[J]. Cell Immunol, 2010,261(2):93-98.
  • 7Wang X, Bao M, Wan M, et al. CpG oligodeoxynueleotide acts as a potent adjuvant for inactivated rabies virus vaccine [J]. Vaccine, 2008,26(15):1893-1901.
  • 8Siegrist C A, Pihlgren M, Tougne C, et al. Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response[J]. Vaccine, 2004,23(5):615-622.
  • 9Mackay I R. Hepatoimmunology: a perspective[J], Immunol Cell Biol, 2002,80(1):36-44.
  • 10欧强,陈良,孙洪清,唐徐英.慢性HBV感染者外周血T淋巴细胞亚群和NK细胞活性变化[J].临床肝胆病杂志,2006,22(4):277-278. 被引量:15

二级参考文献13

  • 1石艳春,翁滨,郑源强,刘丹,杨贵贞.含CpG基序寡核苷酸对rHBsAg免疫小鼠脾脏组织及细胞增殖的影响[J].中国生物制品学杂志,2006,19(2):105-107. 被引量:2
  • 2郑源强,石艳春,杨贵贞.CpG ODN2006对乙型肝炎疫苗免疫BALB/c小鼠抗体产生的影响[J].中国生物制品学杂志,2006,19(3):223-224. 被引量:2
  • 3Hem SL, Hogenesch H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation [J].Expert Rev Vaccines, 2007, 6 (5): 685-698.
  • 4Lee WM. Hepatitis B virus infection [J]. N Engl J Med, 1997, 337 (24): 1733-1745.
  • 5Wang S, Han Q, Zhang N, et ol. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice [J].Immunol Lett, 2010, 127(2): 143-149.
  • 6Wang X, Bao M, Wan M, et al. CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine [J]. Vaccine, 2008, 26 (15): 1893-1901.
  • 7Siegrist CA, Pihlgren M, Tougne C, et al. Coadministration of CpG oligonucleotides enhances the late affinity maturation process of human antihepatitis B vaccine response [J]. Vaccine, 2004, 23 (5): 615-622.
  • 8Jana M, Dasgupta S, Pal U, et al. IL-12 p40 homodimer, the socalled biologically inactive molecule, induces nitric oxide synthase in microglia via IL-12R beta 1 [J]. Glia, 2009, 57 (14): 1553- 1565.
  • 9黄耀宿.肝病分子生物学[M].福建:福建科学技术出版社,2003:101-103.
  • 10Ferrari C,Penna A,Bettoletti A,et al.Cellular immune response to hepatitis B virus encoded antigens in acute and chronic hepatitis B virus infection[J].J Immunol,1990,145:3442 -3449.

共引文献14

同被引文献9

  • 1Trehanpati N,Hissar S,Shrivastav S,et al.,Immunological mechanisms of hepatitis B virus persistence in newborns[J].The Indian journal of medical research,2013,138(5):700.
  • 2Wang Z,J,Zhang H,Yang,et al.Quantitative analysis of HBV DNA level and HBe Ag titer in hepatitis B surface antigen positive mothers and their babies:HBe Ag passage through the placenta and the rate of decay in babies[J].Journal of medical virology,2003,71(3):360-366.
  • 3Milich D,Liang TJ.Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection[J].Hepatology,2003,38(5):1075-1086.
  • 4Shiraki K.Perinatal transmission of hepatitis B virus and its prevention[J].Journal of gastroenterology and hepatology,2000,15(s2):E11-E15.
  • 5Han GR,Cao MK,Zhao W,et al.A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J].Journal of hepatology,2011,55(6):1215-1221.
  • 6Choe BH,Lee JH,Jang YC,et al.Long-term therapeutic efficacy of lamivudine compared with interferon-αin children with chronic hepatitis B:The younger the better[J]Journal of pediatric gastroenterology and nutrition,2007,44(1):92-98.
  • 7Akbar S,Inaba K,Onji M.Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferongamma:abrogation of immune response defect to a T-cell-dependent antigen[J].Immunology,1996,87(4):519.
  • 8Zhao J,Li Y,Jin L,et al.Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-γand Cytotoxicity in Acute Resolved Hepatitis B Patients[J].Plo S one,2012,7(11):e49135.
  • 9齐秀花,王明园,姜建慧.预防乙型肝炎病毒母婴传播的临床研究[J].中国医疗前沿,2009,4(18):20-20. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部